BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6232828)

  • 1. Zimeldine versus amitriptyline in endogenous depression. A double-blind study with special reference to effects on liver function.
    Larsen FW; Hansen CE
    Acta Psychiatr Scand; 1984 Apr; 69(4):343-9. PubMed ID: 6232828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression.
    Huitfeldt B; Montgomery SA
    Acta Psychiatr Scand Suppl; 1983; 308():55-69. PubMed ID: 6230896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind study comparing the efficacy of zimelidine and amitriptyline in endogenous depression.
    O'Connor M; Grigor J
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):127-32. PubMed ID: 6233635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zimeldine tolerability in comparison to amitriptyline and placebo: findings from a multicentre trial.
    Claghorn J; Gershon S; Goldstein BJ
    Acta Psychiatr Scand Suppl; 1983; 308():104-14. PubMed ID: 6230883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zimeldine versus nomifensine. A double-blind study of depressed inpatients.
    Knudsen P; Bjørndal N; Johnsen T; Pfeiffer Petersen K
    Neuropsychobiology; 1984; 11(4):236-42. PubMed ID: 6238240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders.
    Merideth CH; Feighner JP
    Acta Psychiatr Scand Suppl; 1983; 308():70-9. PubMed ID: 6230897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zimeldine in depressive illness--efficacy and safety data.
    Burrows GD; Norman TR; Marriott PF; Davies B
    Acta Psychiatr Scand Suppl; 1983; 308():31-40. PubMed ID: 6230894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo.
    Gelenberg AJ; Wojcik JD; Falk WE; Spring B; Brotman AW; Galvin-Nadeau M
    Compr Psychiatry; 1990; 31(4):307-14. PubMed ID: 2201481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
    Davidson J; Miller R; Van Wyck Fleet J; Strickland R; Manberg P; Allen S; Parrott R
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):115-7. PubMed ID: 6406438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M; Darimont P; Lecoq A; De Nayer A; Evrard JL; Krémer P; Devoitille JM; Dierick M; Mertens C; Mesotten F
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
    Altamura AC; De Novellis F; Guercetti G; Invernizzi G; Percudani M; Montgomery SA
    Int J Clin Pharmacol Res; 1989; 9(6):391-6. PubMed ID: 2699465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
    Möller HJ; Berzewski H; Eckmann F; Gonzalves N; Kissling W; Knorr W; Ressler P; Rudolf GA; Steinmeyer EM; Magyar I
    Pharmacopsychiatry; 1993 May; 26(3):75-8. PubMed ID: 8415897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of a specific MAO A reversible inhibitor (R011-1163) and amitriptyline in depressive illness.
    Norman TR; Ames D; Burrows GD; Davies B
    J Affect Disord; 1985; 8(1):29-35. PubMed ID: 3156909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.